CY1120879T1 - Πολλαπλου συστατικου βιοδραστικος ενδοκολπικος δακτυλιος - Google Patents

Πολλαπλου συστατικου βιοδραστικος ενδοκολπικος δακτυλιος

Info

Publication number
CY1120879T1
CY1120879T1 CY20181100808T CY181100808T CY1120879T1 CY 1120879 T1 CY1120879 T1 CY 1120879T1 CY 20181100808 T CY20181100808 T CY 20181100808T CY 181100808 T CY181100808 T CY 181100808T CY 1120879 T1 CY1120879 T1 CY 1120879T1
Authority
CY
Cyprus
Prior art keywords
fungi
bioactive
intalcaline
ring
multiple ingredient
Prior art date
Application number
CY20181100808T
Other languages
English (en)
Inventor
Shalaby W. Shalaby
Georgios T. Hilas
Original Assignee
Poly-Med, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poly-Med, Inc. filed Critical Poly-Med, Inc.
Publication of CY1120879T1 publication Critical patent/CY1120879T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)

Abstract

Συσκευές ενδοκολπικού δακτυλίου έχουν πολλαπλού συστατικού υποστρώματα απελευθέρωσης φαρμάκου φορτωμένα με τουλάχιστον ένα βιοδραστικό παράγοντα και σχεδιασμένα για να πραγματοποιούν αντισύλληψη ή/και παρέχουν μέσα για να θεραπεύονται ή/και να αποτρέπονται ασθένειες που προκαλούνται από μολυσματώδη βακτηρίδια, μύκητες, ιό και ρετροϊούς, χωρίς να διακυβεύουν την πρωταρχική λειτουργία της κανονικώς ενυπάρχουσας, χρήσιμης κολπικής μικροχλωρίδας σε ασθενείς θήλεα.
CY20181100808T 2007-10-11 2018-08-06 Πολλαπλου συστατικου βιοδραστικος ενδοκολπικος δακτυλιος CY1120879T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/974,140 US8062658B2 (en) 2004-12-14 2007-10-11 Multicomponent bioactive intravaginal ring
PCT/US2008/011617 WO2009048594A2 (en) 2007-10-11 2008-10-09 Multicomponent bioactive intravaginal ring

Publications (1)

Publication Number Publication Date
CY1120879T1 true CY1120879T1 (el) 2020-05-29

Family

ID=40550555

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100808T CY1120879T1 (el) 2007-10-11 2018-08-06 Πολλαπλου συστατικου βιοδραστικος ενδοκολπικος δακτυλιος

Country Status (12)

Country Link
US (2) US8062658B2 (el)
EP (1) EP2424505B1 (el)
CY (1) CY1120879T1 (el)
DK (1) DK2424505T3 (el)
ES (1) ES2682111T3 (el)
HR (1) HRP20181108T1 (el)
HU (1) HUE038934T2 (el)
LT (1) LT2424505T (el)
PL (1) PL2424505T3 (el)
PT (1) PT2424505T (el)
SI (1) SI2424505T1 (el)
WO (1) WO2009048594A2 (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8404272B2 (en) 2003-06-26 2013-03-26 Poly-Med, Inc. Fiber-reinforced composite rings for intravaginal controlled drug delivery
US8399013B2 (en) * 2003-06-26 2013-03-19 Poly-Med, Inc. Partially absorbable fiber-reinforced composites for controlled drug delivery
US8062658B2 (en) 2004-12-14 2011-11-22 Poly-Med, Inc. Multicomponent bioactive intravaginal ring
US9034365B2 (en) * 2008-05-20 2015-05-19 Poly-Med, Inc. Biostable, multipurpose, microbicidal intravaginal devices
WO2010033188A2 (en) * 2008-09-16 2010-03-25 Playtex Products, Llc. Dosages for menstrual suppression, contraception, and hormone replacement therapy, and methods of administering same
PT2381932T (pt) * 2009-01-29 2018-11-15 Fondazione Irccs Istituto Naz Dei Tumori Dispositivo intra-cervical para libertação de medicamentos no tratamento loco-regional do cancro do colo do útero
US9006278B2 (en) * 2010-02-02 2015-04-14 Poly-Med, Inc. Controlled release systems of pluribioactive antifungal drugs and applications thereof
EP2598114A1 (en) * 2010-07-28 2013-06-05 Fondazione Irccs "Istituto Nazionale del Tumori" Therapeutic agent, composition including said agent, implantable device and process for the treatment of cervical cancer and/or for the prevention of the formation of neoplasms in correspondence of the cervix in a human female genital system.
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
ES2896968T3 (es) 2010-11-12 2022-02-28 The Univ Of Utah Research Foundation Dispositivos intravaginales para el suministro controlado de lubricantes
US9393216B2 (en) 2012-11-06 2016-07-19 University Of Washington Through Its Center For Commercialization Vaginal matrices: nanofibers for contraception and prevention of HIV infection
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
CN103735547B (zh) * 2013-12-31 2015-08-19 哈尔滨欧替药业有限公司 双唑泰阴道膨胀栓控释制剂及其制法
CN106456838B (zh) * 2014-04-01 2020-12-29 保利医学公司 避孕装置及相关装置
AU2016323770A1 (en) 2015-09-16 2018-03-29 Dfb Soria, Llc Delivery of drug nanoparticles and methods of use thereof
US20170087344A1 (en) * 2015-09-25 2017-03-30 Therapeutic Solutions International, Inc. Devices and methods for reducing the risk of preterm labor and preterm birth
ES2955884T3 (es) 2017-03-15 2023-12-07 Dfb Soria Llc Terapia tópica para el tratamiento de malignidades de la piel con nanoparticulas de taxanos
KR102666078B1 (ko) * 2017-06-28 2024-05-20 아이쿠리스 게엠베하 운트 코. 카게 항바이러스성 화합물을 포함하는 질내 적용 가능한 장치
WO2019178024A1 (en) 2018-03-16 2019-09-19 Dfb Soria, Llc Topical therapy for the treatment of cervical intraepithelial neoplasia (cin) and cervical cancer using nanoparticles of taxanes
EP4057994A4 (en) * 2019-11-12 2023-12-06 Poly-Med Inc. CONTRACEPTIVE MEDICAL DEVICES
AU2020386519A1 (en) * 2019-11-18 2022-06-09 Daré Bioscience, Inc. Intravaginal ring devices

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629449A (en) 1982-07-29 1986-12-16 Alza Corporation Vaginal dispenser for dispensing beneficial hormone
US6416779B1 (en) 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
EP0891783B1 (en) 1997-07-16 2002-06-12 IsoTis N.V. Device for tissue engineering bone comprising biodegradable thermoplastic copolyester and cultured cells
US7416559B2 (en) 2000-10-27 2008-08-26 Poly-Med, Inc. Micromantled drug-eluting stent
JP2006506442A (ja) 2002-07-09 2006-02-23 ポイント セラピューティクス， インコーポレイテッド ボロプロリン化合物併用療法
US20040260386A1 (en) 2003-01-31 2004-12-23 Shalaby Shalaby W. Absorbable / biodegradable tubular stent and methods of making the same
US8404272B2 (en) 2003-06-26 2013-03-26 Poly-Med, Inc. Fiber-reinforced composite rings for intravaginal controlled drug delivery
US8399013B2 (en) 2003-06-26 2013-03-19 Poly-Med, Inc. Partially absorbable fiber-reinforced composites for controlled drug delivery
US20060240071A1 (en) * 2003-07-31 2006-10-26 Sidney Lerner Non-hormonal vaginal contraceptive
JP2007513650A (ja) 2003-11-20 2007-05-31 アンジオテック インターナショナル アーゲー 移植可能なセンサーおよび移植可能なポンプならびに瘢痕化抑制剤
US20050208095A1 (en) * 2003-11-20 2005-09-22 Angiotech International Ag Polymer compositions and methods for their use
JP5017109B2 (ja) * 2004-07-09 2012-09-05 ザ・ポピュレイション・カウンシル，インコーポレイテッド プロゲステロン受容体モジュレーターを含有する徐放性組成物
ES2371554T3 (es) * 2004-12-14 2012-01-05 Poly-Med, Inc. Dispositivo intravaginal de malla en forma de anillo.
US8062658B2 (en) 2004-12-14 2011-11-22 Poly-Med, Inc. Multicomponent bioactive intravaginal ring
WO2006065973A2 (en) 2004-12-15 2006-06-22 Exostar Corporation Enabling trust in a federated collaboration of networks
US8952075B2 (en) 2008-05-22 2015-02-10 Poly-Med, Inc. Bioactive polymeric liquid formulations of absorbable, segmented aliphatic polyurethane compositions

Also Published As

Publication number Publication date
PL2424505T3 (pl) 2018-10-31
US20080069850A1 (en) 2008-03-20
SI2424505T1 (sl) 2018-09-28
HRP20181108T1 (hr) 2018-09-07
EP2424505A2 (en) 2012-03-07
PT2424505T (pt) 2018-10-03
EP2424505B1 (en) 2018-05-09
HUE038934T2 (hu) 2018-12-28
EP2424505A4 (en) 2013-10-23
US8506988B2 (en) 2013-08-13
LT2424505T (lt) 2018-09-10
DK2424505T3 (en) 2018-07-30
WO2009048594A2 (en) 2009-04-16
US8062658B2 (en) 2011-11-22
WO2009048594A3 (en) 2009-07-30
ES2682111T3 (es) 2018-09-18
US20120024472A1 (en) 2012-02-02

Similar Documents

Publication Publication Date Title
CY1120879T1 (el) Πολλαπλου συστατικου βιοδραστικος ενδοκολπικος δακτυλιος
CY1125077T1 (el) Αγωγη της ανεπαρκειας και ελλειψης βιταμινης d με 25-υδροξυβιταμινη d2 και 25-υδροξυβιταμινη d3
ECSP19078196A (es) Composiciones terapéuticas que comprenden rilpivirina hcl y tenofovir disoproxil fumarato
CL2007001724A1 (es) Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1
BR112015023391A2 (pt) formulações compreendendo conjugado droga-anticorpo anti-egfr
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
MX2009009463A (es) Preparacion de una pelicula de rapida disolucion/desintegracion que tiene una alta proporcion de ingrediente activo.
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
MD4577B1 (ro) Compoziţii masticabile de uz veterinar care conţin agent activ izoxazolinic şi utilizarea acestora în tratamentul sau prevenirea unei infestări sau infecţii parazitare
CR8709A (es) Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos
CY1107440T1 (el) Ενωσεις αρυλουριας εν συνδυασμω με αλλα κυτταροστατικα ή κυτταροτοξικα μεσα για τη θεραπεια ανθρωπινων καρκινων
CR8569A (es) Inhibidores de integrasa de vih
PA8637201A1 (es) Difenilimidazopirimidina e-imidazol aminas como inhibidores de la b-secretasa
ECSP088097A (es) Nuevos regímenes para dispositivos de administración controlada de fármacos para anticoncepción
GT200500307A (es) Compuestos quimicos
ECSP066990A (es) Formulaciones con liberación controlada de principio activo que contienen vardenafilo
CY1111613T1 (el) Μεθοδοι για την αντιμετωπιση της μολυνσης απο hiv
CO5640037A2 (es) Derivados de la quinazolina para el tratamiento del cancer
DOP2009000165A (es) Derivados de oxindol sustituido, medicamentos que los comprenden y uso de los mismos
PA8720801A1 (es) Nuevas combinaciones terapeuticas para el tratamiento de la depresion
BR112012013164A2 (pt) composições farmacêuticas para o estímulo de células-tronco
NO20091955L (no) Antivirale sammensetninger, og fremgangsmater for anvendelse
CL2007002875A1 (es) Composicion farmaceutica recubierta por una pelicula que comprende capecitabina y al menos un disgregante, util en el tratamiento del cancer para pacientes que tienen dificultad para tragar las formas de dosificacion solidas orales.
MX347101B (es) Forma de dosis de disolucion rapida de vacuna oral que usa almidon.
CY1117854T1 (el) Πεπτιδικη φαρμακοτεχνικη μορφη για τοπικη οφθαλμικη χρηση